Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover, Germany.
Eur Radiol. 2021 Sep;31(9):6640-6651. doi: 10.1007/s00330-021-07798-w. Epub 2021 Mar 16.
The individual course of disease in idiopathic pulmonary fibrosis (IPF) is highly variable. Assessment of disease activity and prospective estimation of disease progression might have the potential to improve therapy management and indicate the onset of treatment at an earlier stage. The aim of this study was to evaluate whether regional ventilation, lung perfusion, and late enhancement can serve as early imaging markers for disease progression in patients with IPF.
In this retrospective study, contrast-enhanced dual-energy CT scans of 32 patients in inspiration and delayed expiration were performed at two time points with a mean interval of 15.4 months. The pulmonary blood volume (PBV) images obtained in the arterial and delayed perfusion phase served as a surrogate for arterial lung perfusion and parenchymal late enhancement. The virtual non-contrast (VNC) images in inspiration and expiration were non-linearly registered to provide regional ventilation images. Image-derived parameters were correlated with longitudinal changes of lung function (FVC%, DLCO%), mean lung density in CT, and CT-derived lung volume.
Regional ventilation and late enhancement at baseline preceded future change in lung volume (R - 0.474, p 0.006/R - 0.422, p 0.016, respectively) and mean lung density (R - 0.469, p 0.007/R - 0.402, p 0.022, respectively). Regional ventilation also correlated with a future change in FVC% (R - 0.398, p 0.024).
CT-derived functional parameters of regional ventilation and parenchymal late enhancement are potential early imaging markers for idiopathic pulmonary fibrosis progression.
• Functional CT parameters at baseline (regional ventilation and late enhancement) correlate with future structural changes of the lung as measured with loss of lung volume and increase in lung density in serial CT scans of patients with idiopathic pulmonary fibrosis. • Functional CT parameter measurements in high-attenuation areas (- 600 to - 250 HU) are significantly different from normal-attenuation areas (- 950 to - 600 HU) of the lung. • Mean regional ventilation in functional CT correlates with a future change in forced vital capacity (FVC) in pulmonary function tests.
特发性肺纤维化(IPF)的个体疾病进程差异很大。评估疾病活动度和前瞻性估计疾病进展可能有助于改善治疗管理,并更早地提示开始治疗。本研究旨在评估 IPF 患者的区域性通气、肺灌注和延迟增强是否可作为疾病进展的早期影像学标志物。
在这项回顾性研究中,对 32 例患者在吸气和呼气延迟时进行了两次对比增强双能 CT 扫描,两次扫描的平均间隔为 15.4 个月。动脉期和延迟灌注期获得的肺血容量(PBV)图像可作为肺动脉灌注和实质延迟增强的替代物。吸气和呼气时的虚拟非对比(VNC)图像进行非线性配准,以提供区域性通气图像。图像衍生参数与肺功能(FVC%、DLCO%)、CT 中的平均肺密度和 CT 衍生的肺容积的纵向变化相关。
基线时的区域性通气和延迟增强先于未来的肺容积变化(R - 0.474,p 0.006/R - 0.422,p 0.016)和平均肺密度变化(R - 0.469,p 0.007/R - 0.402,p 0.022)。区域性通气也与 FVC%的未来变化相关(R - 0.398,p 0.024)。
CT 衍生的区域性通气和实质延迟增强功能参数是特发性肺纤维化进展的潜在早期影像学标志物。
•在特发性肺纤维化患者的系列 CT 扫描中,基线时的功能 CT 参数(区域性通气和延迟增强)与肺的未来结构变化相关,这些变化可通过肺容积的丧失和肺密度的增加来衡量。•功能 CT 测量的高衰减区(-600 至-250 HU)与肺的正常衰减区(-950 至-600 HU)之间存在显著差异。•功能 CT 中的平均区域性通气与肺功能测试中用力肺活量(FVC)的未来变化相关。